Late and Chronic Toxicities of New Targeted Therapies

Speaker: Tony Mok

T. Mok offers an overview on most common toxicities related to targeted therapies in NSCLC. He highlights in particular skin, visual and gastrointestinal side-effects, but also underlines that these are generally manageable.

Discussion Points

  • What are important toxicities of new targeted therapies?
  • What are late and/or chronic side-effects from new targeted agents?
  • What are the most important consequences for follow-up, e.g. toxicity prevention and management?